New Device for Enhancement of Liposomal Magnetofection Efficiency of Cancer Cells
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32797
New Device for Enhancement of Liposomal Magnetofection Efficiency of Cancer Cells

Authors: M. Baryshev, D.Vainauska, S. Kozireva, A.Karpovs

Abstract:

Liposomal magnetofection is the most powerful nonviral method for the nucleic acid delivery into the cultured cancer cells and widely used for in vitro applications. Use of the static magnetic field condition may result in non-uniform distribution of aggregate complexes on the surface of cultured cells. To prevent this, we developed the new device which allows to concentrate aggregate complexes under dynamic magnetic field, assisting more contact of these complexes with cellular membrane and, possibly, stimulating endocytosis. Newly developed device for magnetofection under dynamic gradient magnetic field, “DynaFECTOR", was used to compare transfection efficiency of human liver hepatocellular carcinoma cell line HepG2 with that obtained by lipofection and magnetofection. The effect of two parameters on transfection efficiency, incubation time under dynamic magnetic field and rotation frequency of magnet, was estimated. Liposomal magnetofection under dynamic gradient magnetic field showed the highest transfection efficiency for HepG2 cells.

Keywords: Dynamic magnetic field, Lipofection, Magnetofection

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1327931

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1716

References:


[1] F. Scherer, M Anton, U Schillinger, J Henke1, C Bergemann, A Kruger, B Gansbacher and C Plank, Gene Therapy (2002) 9, 102-109.
[2] F. Krötz, C. De Wit, H.Y. Sohn, Zahler S, Gloe T, Pohl U, et al., Magnetofection - a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol Ther 2003;7:700-10.
[3] S. Huth, J. Lausier, S.W. Gersting, C.Rudolph, C.Plank, U. Welsch et al. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med 2004;6:923-36.
[4] A. M. Sauer, K. G. de Bruin , N. Ruthardt, O. Mykhaylyk, C. Plank, C. Bräuchle. Dynamics of magnetic lipoplexes studied by single particle tracking in living cells. J Control Release 2009;137:136-45.
[5] C. Plank, M. Anton, C. Rudolph, J. Rosenecker, F. Krotz. Enhancing and targeting nucleic acid delivery by magnetic force. Expert Opin Biol Ther 2003;3:1-14..
[6] N. Morishita., H. Nakagami, R. Morishita, S. Takeda, F. Mishima, B. Terazono, et al. Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. Biochem Biophys Res Commun 2005;334:1121-6.
[7] E.P. Furlani, K.C. Ng. Nanoscale magnetic biotransport with application to magnetofection. Phys Rev E 2008;77:1-8.
[8] S.W. Kamau, P.O. Hassa, B. Steitz, A. P. Fink, H. Hofmann, M. Hofmann-Amtenbrink, et al. Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field. Nucleic Acids Res 2006;34:e40.
[9] S.C. McBain, U. Griesenbach, S. Xenariou, A. Keramane, C.D. Batich, E..W.F.W, Alton, et al. Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays. Nanotechnology 2008;19:405102.
[10] E.P. Furlani, Magnetic biotransport: analysis and aplplication. Materials 2010, 3, 2412-2446.